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A mouse cell variant carrying in heteroplasmic form a nonsense mutation in the mitochondrial DNA-
encoded ND5 subunit of the respiratory NADH dehydrogenase has been isolated and characterized. The
derivation from this mutant of a large number of cell lines containing between 4 and 100% of the normal
number of wild-type ND5 genes has allowed an analysis of the genetic and functional thresholds operating in
mouse mitochondria. In wild-type cells, ;40% of the ND5 mRNA level was in excess of that required for ND5
subunit synthesis. However, in heteroplasmic cells, the functional mRNA level decreased in proportion to the
number of wild-type ND5 genes over a 25-fold range, pointing to the lack of any compensatory increase in rate
of transcription and/or stability of mRNA. Most strikingly, the highest ND5 synthesis rate was just sufficient
to support the maximum NADH dehydrogenase-dependent respiration rate, with no upregulation of translation
occurring with decreasing wild-type mRNA levels. These results indicate that, despite the large excess of genetic
potential of the mammalian mitochondrial genome, respiration is tightly regulated by ND5 gene expression.
One of the most striking features of the mitochondrial ge-
nomes of both higher and lower eukaryotes is the discrepancy
between the large number of copies of these genomes and the
relatively low rate of expression of the mitochondrial genes (3).
This “copy number paradox” is most clearly illustrated by the
observation that, in HeLa cells, the ratio of rRNA molecules
synthesized per cell generation to rRNA genes is 2 orders of
magnitude lower in the mitochondrial compartment than in
the cytoplasmic compartment (3). Very little is known about
the regulation of gene expression in mammalian mitochondria
and its adaptation to the ATP demands of the cell. In partic-
ular, no information is available as to whether, and under
which conditions, the apparent excess of mitochondrial genetic
potential is utilized by the cell. The observation in HeLa cells
that both the mitochondrial mRNAs and rRNAs are metabol-
ically unstable (21) suggested that the basal rate of transcrip-
tion in these cells is in great excess over the cell requirements
for protein synthesis. On the other hand, in both African green
monkey cells (14) and mouse cells (32), a large increase in
mitochondrial mRNA stability has been observed under con-
ditions where the synthesis of the organelle RNA was blocked.
Regulation of mitochondrial RNA stability has also been sug-
gested to play an important role during rat liver development
(42). While the large excess of both mitochondrial DNA
(mtDNA) and its transcriptional activity could, in principle,
allow a rapid adaptation to increased respiratory and ATP
synthesis demands, it is intriguing that, in some developmental
and physiological situations, an increased level of mitochon-
drial gene expression is frequently accompanied, and possibly
determined, by an increase in the level of mtDNA (9, 49, 50).
Furthermore, there is well-documented evidence of transcrip-
tional regulation of mitochondrial gene expression in rat liver
mitochondria by thyroid hormones (16) and during early em-
bryogenesis in Xenopus laevis (1).
There is also very little information concerning the thresh-
olds operating at the level of mitochondrial translation. Thus,
it is not known how much the rate of mitochondrial protein
synthesis exceeds the requirements for the assembly of the
enzyme complexes capable of supporting a normal rate of
oxidative phosphorylation and whether it can be upregulated
in case of need.
Answers to the issues discussed above would be essential for
understanding how different cells or even different subcellular
compartments adapt their respiratory and ATP-producing ca-
pacity in various developmental and physiological situations.
Furthermore, the discovery of disease-causing mtDNA muta-
tions, affecting either components of the translation apparatus
or subunits of the oxidative phosphorylation complexes, and
the increasing evidence of progressive damage to the oxidative
phosphorylation activities associated with aging and neurode-
generative diseases have raised important questions concern-
ing the genetic and functional thresholds controlling gene
expression and oxidative phosphorylation in mammalian mito-
chondria.
In the present work, the isolation of a nonsense heteroplas-
mic mutation in the mitochondrial gene for ND5, an essential
subunit of the mouse respiratory NADH dehydrogenase (com-
plex I), and the application of specific technologies for the
manipulation of the mitochondrial genome (5, 29, 30) have
allowed the construction of a set of transmitochondrial cell
lines carrying, in a constant nuclear background, various copy
numbers of the wild-type ND5 gene, from ;4 to 100% of the
normal level. Analysis in these transformant cell lines of the
total and wild-type mRNA levels and of the rates of mRNA
translation and complex I-dependent respiration have revealed
a stringent regulation of ND5 gene expression and respiration.
These findings have given novel insights into the regulation of
mitochondrial function in mammalian cells and provided a
paradigm of tight thresholds which are likely to apply to other
cellular processes.
MATERIALS AND METHODS
Cell lines and media. All the cell lines used in the present work were grown in
monolayer culture. The cell line A9 (ATCC CCL-1.4) is a derivative of the L
mouse fibroblast cell line deficient in hypoxanthine-guanine phosphoribosyl
transferase and is, thus, resistant to 8-azaguanine and 6-thioguanine (34) and
incapable of growing in hypoxanthine-aminopterin-thymidine (HAT) medium
(19). This cell line was grown in Dulbecco modified Eagle medium with 4.5 mg
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of glucose/ml (DMEM) supplemented with 10% calf serum and 3 mg of 8-aza-
guanine per ml. The A9-derived rotenone-resistant clone 3A, isolated as previ-
ously described (5), was grown in the above-described medium supplemented
with 1.2 mM rotenone. The mouse cell line LL/2, derived from Lewis lung
carcinoma (7; ATCC CRL-1642), was grown in DMEM supplemented with 10%
calf serum. 3A clone-derived transformants (see below) were also grown in the
same medium. The mtDNA-less (r°) LL/2-m21 cell line, a derivative of LL/2 cells
(see below), was grown in DMEM supplemented with 10% fetal bovine serum
(FBS) and 50 mg of uridine per ml.
Isolation of mtDNA-less LL/2 derivatives and mitochondrion-mediated trans-
formation. The mtDNA-less r° LL/2-m21 cell line was isolated by a modification
of a method described earlier (13, 29), which involved treatment of LL/2 cells
with high concentrations of ethidium bromide (5). In particular, LL/2 cells were
exposed to 5 mg of ethidium bromide per ml for 11 to 12 weeks in medium
supplemented with 50 mg of uridine per ml. Two clones were isolated and tested
for the presence of mtDNA by Southern blot hybridization of a FokI-digested
total cell DNA with a mouse mtDNA probe [clone MumX7.6, carrying the
mtDNA fragment between positions 953 and 8529 in pBluescript II KS(1)],
which was digested with EcoRV and 32P labeled by random priming (17). Both
clones showed complete absence of mtDNA. One of these clones, r° LL/2-m21,
was utilized in the present work. Mitochondrion-mediated transformation of r°
cells by cytoplast fusion was carried out as described previously (29) by fusing 3A
mutant cells, which had been enucleated by centrifugation in the presence of
cytochalasin B, with r° LL/2-m21 cells in the presence of 40% polyethylene glycol
1500 (BDH). Mitochondrial transformants were isolated in DMEM supple-
mented with HAT medium components (i.e., hypoxanthine, aminopterin, and
thymidine) (19) and 10% FBS. The transformant clones were subsequently
cultured in DMEM medium with 10% calf serum. In order to increase the
proportion of mutant mtDNA in one of the r° LL/2-m21 transformants (3A20),
this was cultured in DMEM supplemented with 10% FBS and 50 mg of uridine
and 1 mg of ethidium bromide per ml for 10 days (30). The cells were then
trypsinized and replated at low density (0.5 cell per well) in a 96-well dish in the
same medium without ethidium bromide. Ten days later, individual colonies
were selected, transferred to 100-mm plates, and grown further in medium
lacking uridine.
Chromosome analysis. To distinguish cybrids from hybrids among the r°
LL/2-m21 transformants, cells were arrested in metaphase by treatment with 0.05
mg of colchicine per ml for 3 h. Karyotype analysis was carried out as described
previously (40).
O2 consumption measurements. The medium of the cell lines to be analyzed
was changed with fresh medium (rotenone free in the case of the original 3A
mutant cell line) 24 h before the measurements. The total O2 consumption rate
was determined on cells in DMEM lacking glucose, supplemented with 5%
dialyzed FBS, in a YS oxygraph (model 5300 Biological Oxygen Monitor), as
previously described (29). After the measurement, 100 nM rotenone was added
to the chamber, and the rotenone-insensitive O2 consumption rate was mea-
sured. This rate was subtracted from the total respiration to calculate the rote-
none-sensitive rate. For measurements of O2 consumption in digitonin-perme-
abilized cells (27), about 2 3 106 cells were resuspended in 1 ml of buffer (20 mM
HEPES [pH 7.1], 10 mM MgCl2, 250 mM sucrose), and then 100 mg of digitonin
(1 ml of a 10% dimethyl sulfoxide solution) in 1 ml of buffer was added. After
incubation for 1 min at room temperature, the cell suspension was diluted with
8 ml of buffer. The cells were rapidly pelleted and then resuspended in respira-
tion buffer (20 mm HEPES [pH 7.1], 250 mM sucrose, 2 mM KPi, 10 mM MgCl2,
and 1.0 mM ADP). The measurements were carried out in the chamber of the
YSI oxygraph. The substrates (adjusted to a pH of ;7.0 with NaOH) and
inhibitors were added with Hamilton syringes. The final concentrations were as
follows: malate, 5 mM; glutamate, 5 mM; succinate, 5 mM; glycerol-3-phosphate,
5 mM; ascorbate, 10 mM; N,N,N9,N9-tetramethyl-p-phenylenediamine (TMPD),
0.2 mM; rotenone, 100 nM; antimycin, 20 nM; and KCN, 1 mM.
Enzymatic tests. The mitochondrial fraction of the desired cell type was
isolated from 0.5 to 1.0 ml of packed cells as described previously (44), resus-
pended in 8 ml of 50 mM Tris-HCl buffer (pH 7.5 at 25°C), and sonicated with
a Branson Sonifier for 40 s (four 10-s pulses separated by 15-s intervals) on ice.
Mitochondrial membranes were pelleted by centrifugation at 39,000 rpm in a
Beckman Ty65 fixed-angle rotor for 60 min and resuspended in 500 ml of the
above-described buffer. The oxidoreductase activities were measured, at protein
concentrations of 120 mg/ml for Q1 reduction and 25 mg/ml for K3Fe(CN)6
reduction, in medium containing 20 mM Tris-HCl (pH 7.5 at 25°C), 1 mM KCN,
100 mM NADH, and either 50 mM Q1 (Eisai Co., Tokyo, Japan) or 1 mM
K3Fe(CN)6. The reaction was monitored by absorbance measurements at 275 nm
for the reduction of Q1 (e 5 12,250 M21 cm21) and at 410 nm for the reduction
of K3Fe(CN)6 (e 5 1,000 M21 cm21). The NADH-Q1 oxidoreductase activity of
the LL/2 control samples was .98% sensitive to 100 nM rotenone.
Mitochondrial protein synthesis analysis. To measure the rate of mitochon-
drial protein synthesis, pulse-labeling experiments with [35S]methionine were
performed according to the method of Chomyn et al. (11). Samples of 2 3 106
cells of the desired type were plated on 10-cm petri dishes, incubated overnight,
washed with methionine-free DMEM, and then incubated for 7 min at 37°C in 4
ml of the same medium containing 50 mg of the cytoplasmic translation inhibitor
emetine per ml. Thereafter, [35S]methionine (0.2 mCi [1,175 Ci/mmol] per plate)
was added, and the cells were incubated for 30 min. The labeled cells were
trypsinized, washed, and lysed in 1% sodium dodecyl sulfate (SDS). Samples
containing 40 mg of protein were electrophoresed through an SDS–15 to 20%
exponential polyacrylamide gradient gel. The intensities of the bands were quan-
tified by laser densitometry of appropriately exposed fluorograms or by phos-
phorimager analysis. To measure the protein labeling as a function of time, four
samples of 5 3 105 cells of each of the LL/2 and 3A33 cell lines were plated on
10-cm petri dishes. Labeling conditions were the same as those described above,
except that a greater amount of [35S]methionine (1.2 mCi per plate) was used.
Protein synthesis was stopped by the addition of 4 mM puromycin at 10, 20, 30,
and 45 min. The intensities of the bands were quantified by phosphorimager
analysis after electrophoresis.
Immunoprecipitation experiments. For immunoprecipitation of complex I,
cells were subjected to pulse-chase labeling (12). For this purpose, about 8 3 107
cells were grown for 22 h in the presence of 40 mg of the mitochondrial trans-
lation inhibitor chloramphenicol (CAP) per ml in order to allow the accumula-
tion of the nucleus-encoded subunits of the oxidative phosphorylation apparatus
and, therefore, facilitate the incorporation into these complexes of the mtDNA-
encoded subunits synthesized after the removal of CAP. Labeling was carried out
as described in the previous section, except that emetine was replaced with the
reversible protein synthesis inhibitor cycloheximide, and the incubation time with
[35S]methionine was extended to 2 h; thereafter, the cells were washed and
subjected to a 19-h chase in complete unlabeled medium in the absence of
cycloheximide in order to allow the incorporation of the labeled mtDNA-en-
coded subunits into the complexes. The pulse-chase-labeled cells were then
collected and pelleted to yield ;0.2 ml of packed cells. The mitochondrial
fraction was isolated from these cells by homogenization and differential cen-
trifugation and then lysed with 0.5% Triton X-100 (39). Samples of 120 mg of
protein were incubated at 4°C with 72 mg of gamma globulins from an antiserum
against the COOH-terminal heptapeptide of the human mtDNA-encoded sub-
unit ND4L (38) or from normal rabbit serum. Immunocomplexes were bound to
formaldehyde-fixed Staphylococcus aureus (Zysorbin; Zymed Laboratories, San
Francisco, Calif.) (11), pelleted, and washed repeatedly by centrifugation and
resuspension. The protein was eluted from the immunoadsorbant in the final
pellets with 1% SDS, 5 mM Tris-HCl (pH 8) (25°C), and 1 mM phenylmethyl-
sulfonyl fluoride and then electrophoresed through an SDS–15 to 20% exponen-
tial polyacrylamide gradient gel.
DNA analysis. For ND5 mtDNA sequencing, total DNA samples were isolated
from cells with an Applied Biosystems 340A DNA extractor and then subjected
to PCR amplification of the ND5 gene by using the primers ND5-59-1 and
ND5-39-1 (see below). DNA sequencing of the gel-purified (QIAEXII; Qiagen)
product was carried out by using the ABI PRISM Dye Terminator Cycle Se-
quencing Core (Perkin-Elmer) with the primers ND5-59-2, ND5-59-3, ND5-59-
594, ND5-595, ND5-596, ND5-39-2, ND5-39-3, ND5-39-4, and ND5-39-5 (see be-
low).
The mtDNA content of the various cell lines was determined at the time of O2
consumption measurements by DNA transfer hybridization of total cell DNA
carried out with a slot blot apparatus (29). For this purpose, samples of 2 3 105
cells were lysed in PCR buffer containing 1% NP40 and 100 mg of proteinase K
per ml, incubated for 1 h at 55°C and then for 10 min at 95°C, treated with 0.5
M NaOH for 16 h, blotted in triplicate, and hybridized with a mixture of three
mouse mtDNA-specific probes 32P labeled by random priming (plasmid
MumX1.9, containing the mouse mtDNA sequence from positions 8984 to
10907; plasmid MumX5.1, containing the mtDNA sequence from positions
10907 to 15973; and plasmid MumX7.6, containing the mtDNA sequence from
positions 953 to 8529 [8]). Quantification of the intensities of the bands was done
by using a PhosphorImager (Molecular Dynamics) and the ImageQuant pro-
gram.
Quantification of the mtDNA mutation (a C-to-A point mutation, which
destroys a ClaI site) was carried out by analysis of the products of a restriction
digestion reaction. For this purpose, a 465-bp fragment of the ND5 gene was
amplified by PCR with the primers ND5-59-2 and ND5-39-4 in a 50-ml volume. To
avoid the errors arising from resistance to enzyme digestion of heteroduplexes of
wild-type and mutant mtDNA, the “last cycle hot” PCR was performed (41). For
this purpose, 5 mCi of [a-32P]dATP was added to a sample of the reaction
mixture before the last cycle. A 5-ml sample of the final PCR mixture was then
subjected to ClaI digestion (5 U) in a 20-ml reaction volume at 37°C overnight:
under these conditions, the wild-type ND5 fragment was cut into two small
fragments of 297 and 168 bp, while the mutant ND5 fragment remained intact.
A 5-ml sample of the above-described reaction mixture was subsequently elec-
trophoresed on a 6% polyacrylamide gel. Quantification of the intensity of the
bands was done by phosphorimager analysis.
The sequences of the primers used in this study were as follows: ND5-59-1
(positions 11613 to 11630), GATTGCAAGAACTGCTTA; ND5-59-2 (positions
11785 to 11802), CCCCAATCCTAATTTCAA; ND5-59-3 (positions 12968 to
12986), ACACTAATCGCCACTTCT; ND5-59-4 (positions 12186 to 12203),
TCTTTCCTACTAATTGGA; ND5-59-5 (positions 12761 to 12778), CTCTGG
CTCAATCATTCA; ND5-59-6 (positions 13381 to 13398), CCCTAACTCTCC
TAGACT; ND5-39-1 (positions 13609 to 13592), GGTAGTAGCTGGGTGA
TC; ND5-39-2 (positions 13556 to 13539), CTCGAGATTAATTGAGTA; ND5-
39-3 (positions 12912 to 12895), CTTTTGAGTAGAACCCTG; ND5-39-4
(positions 12248 to 12231), TGCTTGTAGGGCTGCAGT; and ND5-39-5 (po-
sitions 11917 to 11900), TATTCTATATTATTGTGG.
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The sequences of the ND1, ND4, and ND6 genes were determined by PCR
amplification of appropriate overlapping fragments and sequencing of the gel-
purified products. For this purpose, 18- to 20-nucleotide primers were used with
the starting positions of the 59 primers being 2653, 2679, 2951, and 3231 for the
ND1 gene, 10124, 10176, 10451, and 10781 for the ND4 gene, and 13433 and
13496 for the ND6 gene and the starting positions of the 39 primers being 3835,
3796, and 3520 for the ND1 gene, 11644, 11610, 11320, and 11030 for the ND4
gene, and 14202 and 14164 for the ND6 gene.
RNA analysis. Total cell RNA was isolated by the RNAzol B procedure
(Tel-Test, Inc., Friendswood, Tex.), which is based on a modification of the
single-step method by acid guanidinium thiocyanate-phenol-chloroform extrac-
tion (10). RNA extracted from 1 3 106 to 3 3 106 cells was treated with 30 U of
RNase-free DNase I (Boehringer Mannheim) at 37°C overnight in Taq buffer
supplemented with 3 mM MgCl2 and 100 U of RNasin (Promega). The analysis
of the genotypes of the transcripts was carried out by reverse transcription
(RT)-PCR (6) and restriction digestion by ClaI. The RT was carried out in a
20-ml reaction mixture containing 1 mg of RNA (dissolved in water), 0.4 mg of
random hexamer mixture, 10 mM dithiothreitol, 40 U of RNasin, 0.5 mM
concentrations of each of the four deoxynucleoside triphosphates (dNTPs), 4 ml
of 53 RT buffer and 200 U of mouse mammary leukemia virus reverse tran-
scriptase (dNTPs were from Amersham; all other products were from Promega).
The reaction was carried out at 37°C for 1 h, followed by 5 min of heating at 95°C
to inactivate the enzyme. Then, 4-ml samples of each cDNA mixture and, as a
control, of reaction mixtures from which reverse transcriptase had been omitted
were used directly as substrates for PCR. The PCR and the ClaI digestion were
carried out as for DNA analysis. For quantification of the ND5 mRNA, an RNA
transfer hybridization analysis was carried out as follows. First, 20 mg of the total
cell RNA was fractionated by electrophoresis through a 1.4% agarose–2.2 M
formaldehyde gel; then it was transferred onto a Zeta-probe membrane (Bio-
Rad) and hybridized to a mouse mtDNA-specific probe 32P labeled by random
priming (plasmid MumX5.1, containing the mtDNA sequence from positions
10907 to 15973, which include the ND5, ND6 and CYTb genes and part of the
ND4 gene [8]). Quantification of the intensity of the bands was done by phos-
phorimager analysis.
RESULTS
Isolation of a mouse ND5 gene mutant. In previous work (5),
the mouse fibroblast cell line A9 (deficient in hypoxanthine-
guanine phosphoribosyltransferase [HGPRT]) was screened
for mutants defective in one or another of the mtDNA-en-
coded subunits of complex I by following an approach based on
the cell resistance to high concentrations of rotenone, a spe-
cific inhibitor of the enzyme (5, 24, 25). Eleven clones, which
had been adapted to grow in the presence of 1.2 mM rotenone
by exposing them to increasing concentrations of the drug (5),
all showed a variable decrease, relative to the A9 level, in
malate-glutamate-dependent respiration, which usually re-
flects the rate-limiting activity of complex I, whereas the suc-
cinate–glycerol-3-phosphate (G-3-P)-driven respiration, which
usually reflects the activity of ubiquinone-cytochrome c oxi-
doreductase (complex III), and the TMPD-ascorbate-driven
respiration, which reflects the activity of cytochrome c oxidase
(COX; complex IV), were not significantly decreased. The
clone most severely affected, clone 4A, was analyzed further
and shown to carry a near-homoplasmic frameshift mutation in
the ND6 subunit gene (5). In the present work, another of the
11 clones, clone 3A, was tested and found not to exhibit any
decrease, relative to the level in the parental A9 cells, in
overall respiration (Fig. 1a), but a significant reduction
(;34%) in malate-glutamate-dependent O2 consumption
(Fig. 1b). This reduction contrasted with the lack of any de-
crease in succinate–G-3-P-dependent respiration and a slight
increase in TMPD-ascorbate-driven respiration.
In order to investigate the genetic origin of the rotenone
resistance and of the respiratory defect in the 3A cells and the
relationship between the two phenomena, advantage was taken
of the mtDNA-less (r°) cell repopulation approach (29). The
r° LL/2-m21 cell line had been isolated in this laboratory from
the mouse LL/2 cell line after long-term treatment with
ethidium bromide (5; see also Materials and Methods). Mito-
chondria from 3A cells were transferred into the mouse r° cells
by fusion of the latter with a population of predominantly
enucleated cells (cytoplasts) derived from the mutant cells.
The cybrids and hybrids were selected for in DMEM without
the addition of uridine (a medium in which r° cells cannot
survive [29]) and supplemented with HAT medium compo-
nents in order to kill any nonenucleated HGPRT-deficient 3A
cells. Eleven transformants, named 3A3, 3A6, 3A11, 3A13,
3A16, 3A19, 3A20, 3A25, 3A27, 3A31, and 3A33, were se-
lected for further analysis.
Karyotype analysis of the 3A transformants revealed a range
of chromosome numbers (43 to 54) similar to those of the LL/2
and r° LL/2-m21 cell lines (i.e., ;42), as expected for cybrids.
None of the transformants was able to grow in the presence of
1.2 mM rotenone (data not shown). These results strongly
suggested that the resistance to rotenone was due to a muta-
tion in a nuclear gene, as previously observed for the rotenone-
resistant human and mouse cells (5, 24, 25).
In confirmation of earlier findings (5), the rates of overall O2
consumption (Fig. 1a) and of malate-glutamate-dependent res-
piration (Fig. 1b) in A9 cells were found to be significantly
lower than in LL/2 cells. The previous experimental evidence
strongly suggested that this was due to some difference in the
nuclear backgrounds of A9 and LL/2 cells (5). Accordingly, in
the present work, the O2 consumption rates of the r° LL/2-m21
transformants were compared with those of the LL/2 cells,
which had the same nuclear background as the r° cells. It was
found that, in contrast to what occurred in rotenone resistance,
the defect in complex I activity of the clone 3A cells was
transferred into r° cells with their mtDNA, pointing to an
FIG. 1. Total respiration rate (a) and activities of the enzymes of the mito-
chondrial respiratory chain (b) in the three parental cell lines (A9, 3A, and LL/2),
11 r° LL/2-m21 cell transformants, and 4 3A-20 ethidium bromide (E.B.)-treated
derivatives. In both panels, the data are displayed in the following order: first for
the A9, 3A, and LL/2 cell lines; then for the transformants; and, finally, the 4
3A-20 derivatives. The cell lines in the latter two groups are arranged in order of
decreasing malate-glutamate-dependent respiration. In panel a, the total respi-
ration rate was measured on ;2 3 106 cells. In panel b, the activities of the
various components of the respiratory chain were determined on 2 3 106 cells as
respiration dependent on malate-glutamate (solid bars), succinate–G-3-P (open
bars), and TMPD-ascorbate (hatched bars). Three to five determinations were
made for each cell line. The error bars indicate the standard error of the mean
(SEM).
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mtDNA mutation as its cause. Thus, the rates of malate-glu-
tamate-dependent respiration in the 11 transformants analyzed
were reduced, relative to that in LL/2 cells, by 7 to 78%, as
shown in decreasing order in Fig. 1b. By contrast, the rate of
overall respiration was increased by 2 to 54% in all transfor-
mants, except in 3A20, in which it was decreased by ;32%
(Fig. 1a). A plausible explanation of the increase in overall
respiratory capacity in nearly all of the transformants was pro-
vided by the observation that the succinate–G-3-P-dependent
respiration rate was increased in all transformants by 31 to
91%, relative to the LL/2 rate, while the TMPD-ascorbate-
dependent respiration rate was increased by 66 to 119% (Fig.
1b).
Among the 11 r° LL/2-m21 transformants analyzed, 3A20
showed both the lowest overall respiration rate (3.9 fmol/min/
cell; 67% of the LL/2 rate) (Fig. 1a) and the lowest malate-
glutamate-dependent respiration rate (0.95 fmol/min/cell; 22%
of the LL/2 rate) (Fig. 1b). In order to increase further the
proportion of the putative mutant mtDNA in this transfor-
mant, an approach based on treatment of the cells with a low
concentration of the mtDNA replication selective inhibitor
ethidium bromide (30) was used. The goal was to reduce the
mtDNA level to an average of one molecule per cell, a state in
which the majority of the cells would be expected to be ho-
moplasmic for mutant or wild-type mtDNA. At this time, with-
drawal of ethidium bromide would allow the single mtDNA
molecule to repopulate the cell. Previous work had, in fact,
shown that cells partially depleted of mtDNA by treatment
with ethidium bromide rapidly regain a normal level of
mtDNA upon removal of the drug (51). Accordingly, 3A20
cells were grown for 10 days in DMEM supplemented with 50
mg of uridine per ml and containing 1 mg of ethidium bromide
per ml. Single cells were cloned, as detailed in Materials and
Methods, and among 32 clones isolated, the four which had the
lowest overall and malate-glutamate-dependent respirations
were selected (Fig. 1). Among them, the 3A20-4 clone exhib-
ited the most significant reduction in total respiration rate (1.9
fmol/min/cell; 32% of the LL/2 rate) and in malate-glutamate-
dependent respiration rate (0.44 fmol/min/cell; 10% of the
LL/2 rate).
The transfer of the complex I defect into r° cells with 3A cell
mtDNA pointed strongly to the presence in this DNA of a
mutation in one of the genes encoding subunits of the respi-
ratory NADH dehydrogenase. In order to obtain some indica-
tion of the possible site of this mutation, the mitochondrial
translation products of the various cell lines were labeled with
[35S]methionine for 30 min in the presence of the inhibitor of
cytoplasmic protein synthesis emetine. As can be seen in Fig.
2a, in the electrophoretic patterns from the 11 transformants
and the four ethidium bromide-derived 3A20 subclones, the
only obvious difference from the wild-type patterns of A9 and
LL/2 cells is the reduction in the relative labeling of the
polypeptide identified from its electrophoretic mobility as the
ND5 gene product. A control experiment utilizing different
[35S]methionine pulses verified that the labeling of the ND5
polypeptide (Fig. 2b), as well as the overall labeling of the
mitochondrial translation products (not shown), was linear
over the 30-min period in both the parental line LL/2 and the
3A33 transformant. Therefore, the 30-min labeling data reflect
the rates of synthesis of the various polypeptides. In Fig. 2a,
the electrophoretic patterns for the transformant and ethidium
bromide-derived clones are displayed, with minor deviations,
in order of decreasing malate-glutamate-dependent respira-
tion rate of the cell lines. After correction for the obvious
differences in loading of lanes 3A25, 3A27, and 3A20, a gen-
eral trend toward a progressive decrease in the relative inten-
sity of the ND5 band is clear, indicating a decrease in the rate
of synthesis of the ND5 protein. These observations pointed to
the ND5 gene as the best candidate for carrying the putative
mutation.
The ND5 mutation is a C-to-A transversion creating a mi-
tochondrial stop codon. On the basis of the above findings, the
PCR-amplified ND5 gene was sequenced by the chain termi-
nation method (43) in both the wild-type cell line LL/2 and the
mutant cell line 3A20-4. As shown below, a C-to-A transver-
sion was found at position 12081 (8), which changed the argi-
nine codon CGA to the mitochondrial stop codon AGA (2):
12081
u
DNA AATCGATTC 3 AATAGATTC
Protein Asn Arg Phe 3 Asn Stop
The mouse ND5 gene encodes a 607-amino-acid polypeptide.
The C-to-A mutation resulted in a 115-amino-acid truncated
polypeptide. It seems very likely that this truncated protein is
an unstable product, as previously shown for the prematurely
terminated human ND4 and ND5 polypeptides (24, 25) and
the mouse ND6 polypeptide (5). However, the near identity in
size of this truncated product with the ND3 subunit (114 amino
acids) prevented its identification in the electrophoretic pat-
terns of newly synthesized proteins from the mutant cell lines.
The sequence data showed that the C-to-A mutation at
position 12081 also destroyed a ClaI restriction site (ATCG
AT, underlined in the sequence shown above), and this was
confirmed by the ClaI digestion of a PCR-amplified ND5 frag-
ment (Fig. 3a). The quantitative analysis of the ClaI digestion
patterns revealed that, in the original 3A mutant clone, there
was about 20% of ND5 mutation-carrying mtDNA. In the
transformants 3A3, 3A19, and 3A31, mutant mtDNA was not
detectable above a very weak background signal observed also
in LL/2 and, in clones 3A20 and 3A20-4, the mutant mtDNA
had increased up to 85 and ;96%, respectively (Fig. 3b). To
exclude any additional structural alteration in any of the sub-
units of NADH dehydrogenase, the genes for the subunits
which have been found to be affected by disease-causing mu-
tations, i.e., ND1, ND4, and ND6 (47), were completely se-
quenced. No sequence difference from the corresponding
genes in A9 mtDNA was found.
A quantification of the mtDNA content of the transformant
cell lines, carried out by hybridization with mouse mtDNA
probes, failed to reveal any significant difference in mtDNA
level from the LL/2 control value (the deviations being #36%,
mostly in the range of 4 to 25%), except in clones 3A11 and
3A20 (Fig. 3c). The latter two clones exhibited 71 and 130%
increases in mtDNA content, respectively. These increases
presumably reflected a compensatory amplification of mtDNA,
a phenomenon which was previously observed (5, 53).
Further characterization of the 3A20-4 ND5 mutant cells.
To further characterize this ND5 mutant cell, a biochemical
analysis of the activity of complex I was carried out by enzy-
mological tests on partially purified mitochondrial membranes
(24). The NADH oxidoreductase activity was determined with
a water-soluble ubiquinone analog (Q1) in both LL/2 wild-type
cells and 3A20-4 mutant cells. The NADH-K3Fe(CN)6 oxi-
doreductase activity of the membranes, which is catalyzed by
the nucleus-encoded flavoprotein fragment of the enzyme (20),
was also measured in the same cells.
As shown in Table 1, the NADH-Q1 oxidoreductase activity
of the 3A20-4 clone mitochondrial membranes was reduced to
less than ;1.4% of the LL/2 activity. By contrast, the NADH-
K3Fe(CN)6 oxidoreductase activity did not appear to be sig-
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nificantly affected in the 3A20-4 clone membrane preparation.
It has previously been shown with Neurospora crassa that the
flavoprotein fragment is assembled independently of the mem-
brane fragment, which contains the mtDNA-encoded subunits
(48), and the same is probably true in mammalian cells (5, 24,
25). Therefore, the NADH-K3Fe(CN)6 oxidoreductase activity
was used to correct for differences in mitochondrial content
among the crude mitochondrial membrane preparations from
the two cell lines tested. The corrected activities are shown in
Table 1. It appears that the normalized NADH-Q1 oxidoreduc-
tase activity was reduced in 3A20-4 cells to less than 1.7% of
the LL/2 activity.
In order to investigate whether, in the cell lines carrying a
nonsense mutation in ND5, the assembly of the other mtDNA-
encoded subunits is affected, immunoprecipitation experi-
ments were carried out by using antibodies against the COOH-
FIG. 2. Electrophoretic analysis of SDS mitochondrial lysates from the [35S]methionine 30-min-pulse-labeled 3 parental lines, 11 r° LL/2-m21 transformants, and
4 ethidium bromide-derived 3A20 subclones (a), kinetics of the ND5 labeling in LL/2 and 3A33 cells (b), and electrophoretic patterns of immunoprecipitates obtained
from Triton X-100 mitochondrial lysates of pulse-chased LL/2 and 3A20-4 cells with gamma globulins from an antiserum against the human ND4L subunit (ND4L)
or from normal rabbit serum (NS) (c). For details, see Materials and Methods. In panel a, the patterns for the transformants and 3A20-4 are arranged, with minor
deviations, in the order of decreasing malate-glutamate-dependent respiration rate.
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terminal synthetic heptapeptide of the mtDNA-encoded
subunit ND4L of human complex I, which is located in the
membrane arm (38). These antibodies had previously been
shown to be able to precipitate all mtDNA-encoded subunits
and, therefore, presumably the whole mouse complex I, from a
0.5% Triton X-100 mitochondrial lysate (5), and thus were
expected to reveal whether the mtDNA-encoded subunits of
the mutant cell lines are assembled into the membrane arm of
complex I. For the purpose of these immunoprecipitation ex-
periments, as detailed in Materials and Methods, LL/2 and
3A20-4 cells were labeled for 2 h with [35S]methionine in the
presence of the reversible inhibitor of cytoplasmic protein syn-
thesis cycloheximide and then chased for 19 h in complete
unlabeled medium in the absence of the inhibitor. As shown in
Fig. 2c, when a 0.5% Triton X-100 mitochondrial lysate from
pulse-chased LL/2 cells was incubated with gamma globulins
from the anti-ND4L antiserum, the antibodies precipitated
several mtDNA-encoded complex I subunits, in particular,
clearly recognizable, ND1, ND2, ND3, ND4, ND5, and ND6.
By contrast, no evidence of these subunits could be seen in the
corresponding immunoprecipitate obtained with normal serum
gamma globulins. A nonspecific precipitate of COI, COII, A6,
and A8 polypeptides was observed, for unknown reasons, in
the precipitate obtained when gamma globulins of either nor-
mal serum or anti-ND4L antiserum were used. In the mito-
chondrial lysate from mutant 3A20-4 cells, which lacked almost
completely the ND5 product, all the recognizable remaining
mtDNA-encoded complex I subunits, i.e., ND1, ND2, ND3,
ND4, and ND6, were also immunoprecipitated, although to a
somewhat reduced extent compared to levels produced by the
lysate from LL/2 cells. The above results indicated that the lack
of ND5 subunit does not prevent the assembly of the mem-
brane arm of complex I, as was previously shown for human
cells lacking ND5 (25), although it reduces the efficiency of this
process or affects the stability of the membrane arm.
Effect of ND5 gene dosage alteration on mutant and wild-
type ND5 mRNA levels. The availability of a set of r° LL/2-m21
transformants and ethidium bromide-derived 3A20 subclones
carrying, in a constant nuclear background, a content of func-
tional ND5 genes which varied over a wide range, from ;4 to
100% of the wild-type LL/2 level, allowed an analysis of the
genetic and functional thresholds operating in the expression
of this gene. In particular, the effects of the dosage of ND5
genes on the ND5 mRNA level, the ND5 synthesis rate, and
the assembly of a functional NADH dehydrogenase were in-
vestigated in detail. In this analysis, the cell line 3A3, which
had virtually 100% wild-type ND5 genes and an mtDNA con-
tent very close to that of the LL/2 parental line (Fig. 3b and c)
and exhibited a nuclear background and mtDNA haplotype
identical to those of all LL/2-m21 transformants and ethidium
bromide-derived 3A20 subclones, was used as a reference for
comparison purposes.
RNA transfer hybridization experiments, in which a mouse
mtDNA fragment carrying the sequences of the ND5, ND6,
and CYTb genes and of part of the ND4 gene was used as a
probe, and the data of ND5 hybridization to the ND4, ND6,
and CYTb sequences were utilized for normalization showed
that almost all transformants and ethidium bromide-derived
3A20 subclones had a total ND5 mRNA level that was approx-
imately constant, independent of the proportion of mutant
genes. Only two ethidium bromide-derived subclones (20-25
and 20-4), which are nearly homoplasmic for mutant mtDNA
(containing 6.2 and 4.0% wild-type mtDNA, respectively), ex-
hibited a significantly reduced mRNA level (by 35 to 40%
relative to the reference 3A3 level) (Fig. 4a). In other experi-
ments, the proportions of wild-type and mutant ND5 mRNAs
were analyzed by taking advantage of the destruction of the
ClaI site produced by the C12081A transversion. Thus, by
RT-PCR it was shown that, in every transformant or ethidium
TABLE 1. Measurements of NADH-Q1 and NADH-K3Fe(CN)6
oxidoreductase activities in mitochondrial membranes isolated from
LL/2 and 3A20-4 cellsa
Cell line
Avg activity (nmol/min/mg, 6 2 SEM)b NADH-Q1/
NADH-
K3Fe(CN)6
(103)c
NADH-Q1
oxidoreductase
NADH-
K3Fe(CN)6
oxidoreductase
LL/2 11.0 (61.2) 2,079 (6245) 5.3
3A20-4 ,0.15 1,693 (6150) ,0.089 (,1.7)
a The values for NADH-Q1 represents the total activity, with .98% being
rotenone sensitive.
b Determinations were made in triplicate.
c Value in parentheses represents the percentage of normalized NADH-Q1
oxidoreductase activity in 3A20-4 relative to that in LL/2.
FIG. 3. Quantification of the A12081C mutation, by ClaI digestion of a
PCR-amplified ND5 fragment (a and b), and of total mtDNA content, by slot
blot hybridization analysis (c), in the parental cell lines, transformants, and
ethidium bromide (E.B.)-derived 3A20 subclones. In panel c, the mtDNA con-
tent of the various cell lines is expressed relative to the value in LL/2 cells. Two
determinations of the proportion of wild-type ND5 genes and three to six de-
terminations of mtDNA content were made for each cell line. The error bars
indicate the SEM.
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bromide-derived subclone, the proportion of wild-type ND5
mRNA was very close to the proportion of wild-type ND5
genes (Fig. 4b). Control experiments, in which reverse tran-
scriptase was omitted, failed to yield any PCR products, as
expected.
Effect of wild-type ND5 mRNA level alteration on ND5 syn-
thesis rate. In order to investigate how the rate of ND5 protein
synthesis varied in the 15 r° LL/2-m21 transformants and
ethidium bromide-derived subclones as a function of the
amount of wild-type ND5 mRNA, the ND5 labeling data of the
various samples analyzed in the experiments shown in Fig. 2a
were normalized for variation in overall mitochondrial protein
labeling associated with differences in lane loading or other
experimental factors. As shown in Fig. 5, where the normalized
rates of ND5 synthesis in the various transformants and
ethidium bromide-derived clones are expressed relative to the
reference 3A3 transformant rate and plotted versus the per-
centage of wild-type ND5 mRNA, a threshold phenomenon
was observed. It appears, in fact, that the relative rate of ND5
synthesis starts declining below the control rate when the per-
centage of wild-type ND5 mRNA, which is equivalent to the
proportion of wild-type ND5 genes (Fig. 4b), becomes lower
than 60% of the control. This means that 60% of the normal
level of functional ND5 mRNA is adequate to maintain a
normal rate of ND5 protein synthesis. The same threshold was
observed when the rates of ND5 protein synthesis were nor-
malized relative to the labeling of the CYTb and/or ND2 band
(data not shown).
Dependence of a functional complex I assembly on ND5
protein synthesis. The evidence obtained previously (25) and
in the present work has clearly indicated that the ND5 subunit
is essential for complex I activity in human cells and mouse
cells. In order to investigate the control that the synthesis of
the ND5 subunit plays on the assembly of a functional NADH
dehydrogenase, the malate-glutamate-dependent respiration
rates determined in digitonin-permeabilized transformants
and ethidium bromide-derived subclones (Fig. 1b) and ex-
pressed relative to the 3A3 reference value were plotted versus
the corresponding rates of ND5 subunit synthesis, as deter-
mined in the experiments of Fig. 2a. The latter values had been
normalized to the corresponding overall mitochondrial protein
synthesis rates and also expressed relative to the 3A3 reference
value. It appears that, with decreasing protein synthesis rate,
the malate-glutamate-dependent respiration rate decreases
nearly in parallel (Fig. 6a). This surprising result clearly indi-
cates that there is very little excess of ND5 protein synthesis
capacity over that required to maintain a normal rate of as-
sembly of a functional complex I.
In order to have an estimate of the control that the ND5
synthesis rate plays on complex I activity in intact cells, the
rotenone-sensitive endogenous respiration rates of the various
cell lines, which reflect the contribution of complex I to the
total respiration, were plotted versus the corresponding rates
of ND5 synthesis. The proportions of the endogenous respira-
tion rate which was rotenone sensitive had been previously
determined to be ;85, ;67, and ;50% in the cell lines which
had, respectively, 30 to 100, ;10, and ;5% wild-type mtDNA
(data not shown). As shown in Fig. 6b, the rotenone-sensitive
FIG. 4. Quantification of total ND5 mRNA in the r° LL/2-m21 transfor-
mants and ethidium bromide-derived 3A20 subclones by RNA transfer hybrid-
ization (a) and relationship of the proportion of wild-type ND5 mRNA, as
determined by RT-PCR, to the proportion of wild-type ND5 genes (b). The
average total ND5 mRNA content per cell was normalized as detailed in the text
and expressed relative to the value for the transformant 3A3, which has virtually
100% wild-type ND5 genes (Fig. 3b). Three to five determinations of total ND5
mRNA content and three determinations of the proportion of wild-type ND5
mRNA by RT-PCR were made for each cell line. The error bars represent the
SEM; the error bars that fall within the individual data symbols are not shown.
FIG. 5. Relationship between the ND5 synthesis rate, expressed relative to
the rate in the 3A3 transformant, and the proportion of wild-type ND5 mRNA
in the r° LL/2-m21 transformants and ethidium bromide-derived 3A20 sub-
clones. The individual values for the rate of ND5 protein labeling, as determined
by laser densitometry of appropriately exposed fluorograms, were normalized to
the overall protein labeling. Two independent labeling experiments and two
electrophoretic analyses of the mitochondrial translation products after each
labeling were performed for each cell line. Almost identical curves were obtained
by measuring the intensities of the ND5 bands by phosphorimager analysis
and/or normalizing the data to the intensities of the CYTb and/or ND2 band (not
shown). Symbols are as defined for Fig. 4.
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respiration rates, expressed relative to the 3A3 reference value,
remain fairly constant with a decreasing rate of ND5 synthesis,
until this value reaches ca. 80% of the control value, and then
declines progressively to nearly zero.
To obtain an estimate of the threshold for the capacity of
ND5 genes to support respiration, the malate-glutamate-de-
pendent and rotenone-sensitive respiration rates, expressed
relative to the 3A3 reference values, were plotted against the
percentage of wild-type genes in the transformant and
ethidium bromide-derived cell lines analyzed in the present
work. Figure 7 shows the minimum number of wild-type ND5
genes required to maintain a normal rate of rotenone-sensitive
respiration or malate-glutamate-dependent respiration. The
difference in behavior between the two parameters is discussed
below.
DISCUSSION
In the present work, the structural alteration of the ND5
gene in 3A, a derivative of the mouse cell line A9, was found
to be a nonsense mutation converting an arginine codon to the
mitochondrial stop codon AGA. This is in contrast to the other
complex I-defective mutants previously isolated by the rote-
none resistance method (5, 24, 25), which exhibited frameshifts
corresponding to homopolymeric tracts, presumably due to
stuttering of the g DNA polymerase. As discussed for these
mutations, also the 12081 mutation analyzed here is likely to
have preexisted in the A9 cell population and to have then
been selected for by a combination of a replicative advantage
of the mutant mtDNA molecules (33, 52) and of a progressive
adaptation to an exclusively glycolytic energy metabolism. This
adaptation would have made the cells complex I independent
and rotenone insensitive (25). No mutation was detected in any
of the other mtDNA genes encoding subunits of NADH de-
hydrogenase in which disease-causing mutations have been
previously identified (ND1, ND4, and ND6) (47). Further-
more, in clone 3A and in the r° LL/2-m21 transformants and
ethidium bromide-derived subclones, no change was observed
in the rate or pattern of mitochondrial translation other than
the decrease in the rate of synthesis of the ND5 subunit. These
observations clearly indicated that the ND5 mutation detected
here was responsible for the physiological changes observed in
these cell lines. Further support for this conclusion came from
the close similarity in phenotype of the mouse ND5 mutant
analyzed here and from the human ND5 frameshift mutant
investigated earlier (25). Particularly important is the confir-
mation of the previous finding that the ND5 subunit is essential
for the activity of complex I but is not required for the assem-
bly of the other mtDNA-encoded subunits of the complex (25).
Transfer of mitochondria from clone 3A to the mtDNA-less
r° LL/2-m21 generated a large set of transformants which
exhibited a proportion of mutant mtDNA varying between 0
and 85% compared with the 20% mutant mtDNA proportion
of the original clone 3A. This large heterogeneity in mutation
content among the transformants presumably reflected mainly
the original intercellular variation in the 3A cell population. A
surprising finding in the analysis of the transformants and the
ethidium bromide-derived subclones was a general increase in
the rates of both succinate–G-3-P-dependent and TMPD-
ascorbate-dependent respiration, which showed no correlation
with the decrease in malate-glutamate-dependent respiration
or an increase in mtDNA content. This phenomenon presum-
ably reflected a better functionality of complex III and complex
IV carrying 3A mtDNA-encoded subunits in the LL/2 nuclear
FIG. 6. Relationship between rate of malate-glutamate-dependent respira-
tion (a) or rate of rotenone-sensitive respiration (b), as expressed relative to the
rate in the 3A3 transformant, and relative ND5 synthesis rate in the r° LL/2-m21
transformants and ethidium bromide-derived 3A20 subclones. Symbols are as
defined for Fig. 4.
FIG. 7. Relationship between malate-glutamate-dependent respiration rate
(F) or rotenone-sensitive respiration rate (h), as expressed relative to the rate in
the 3A3 transformant, and proportion of wild-type ND5 genes in the r° LL/2-
m21 transformants and ethidium bromide-derived 3A20 subclones. For compar-
ison, the relative rate of ND5 protein synthesis (dashed line) is also shown.
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background. These observations illustrate clearly the influence
of the nuclear background on the biochemical phenotype of
the transmitochondrial cell lines, with obvious implications for
future therapeutic approaches based on mitochondria transfer.
Lack of upregulation of transcription and mRNA stabiliza-
tion with decreasing wild-type ND5 gene copy number. The
present work has yielded the surprising findings that, in all
transformants and ethidium bromide-derived subclones, the
total ND5 mRNA had an almost constant level, except for a
significant decrease (35 to 40%) in two transformants nearly
homoplasmic for the mutation (Fig. 4a), and that the propor-
tions of wild-type ND5 gene and wild-type ND5 mRNA were
almost identical in all cell lines (Fig. 4b). These observations
have clearly pointed to the lack of a compensatory upregula-
tion of transcription of the ND5 gene and/or to an increase in
stability of the ND5 mRNA under conditions where the de-
crease in wild-type ND5 gene copy number caused a significant
decrease in rates of ND5 synthesis and of complex I-dependent
respiration. In particular, the absence of evidence of any in-
crease in metabolic stability of the ND5 mRNA stands in
striking contrast to previous observations indicating a pro-
nounced stabilization of the mitochondrial mRNAs in African
green monkey cells (14) and in mouse cells (32) under condi-
tions where mtDNA transcription was severely blocked. Since,
in the present experiments, no evidence of transcription inhi-
bition was found, one would have to conclude that either the
increase in mitochondrial mRNA stability in mammalian cells
is a compensatory phenomenon intimately connected with a
block in transcription activity or that the ND5 mRNA escapes
this regulation. Furthermore, the near identity of the mutant-
to-wild-type ratios in the ND5 genes and the ND5 mRNA
indicated that nonsense mutation-activated degradation of
mRNA, which has been well established for cytoplasmically
translated mRNAs in eukaryotic cells (37), does not operate
effectively in the case of the mitochondrial ND5 mRNA.
ND5 mRNA in wild-type cells is in significant excess over
the requirement for normal protein synthesis but lacks the
capacity of translational upregulation. The observation that
transformants carrying $60% of the wild-type ND5 mRNA
level were capable of carrying out a normal rate of ND5 syn-
thesis (Fig. 5) indicated clearly that, in wild-type cells, ;40% of
the ND5 mRNA is in excess of the level required for the
maximal rate of ND5 synthesis. This finding should be corre-
lated with previous observations indicating that, in cultured
human cells, the amounts of different mitochondrial tRNAs
investigated are in two- to threefold excess of the levels re-
quired to support a normal rate of protein synthesis (15, 22,
23). This suggests that the rate of assembly of the mitochon-
drial translation apparatus exceeds to a significant extent the
requirements for normal protein synthesis. On the other hand,
the observation made in the present work that, when the con-
centration of functional ND5 mRNA falls below the thresholds
required for normal malate-glutamate-dependent or rotenone-
sensitive respiration, the mitochondrial protein synthesis rate
continues to decline progressively to zero with decreasing
mRNA levels indicates that the cells investigated here have no
capacity to upregulate translation of this mRNA. It is signifi-
cant, in this connection, to mention the previous observations
that, among the mtDNA-encoded proteins synthesized in iso-
lated rat brain synaptosomes (35) and in isolated rat quadri-
ceps muscle fibers (4), the ND5 protein was apparently specif-
ically missing or strongly underrepresented, despite the
presence of a normal level of its mRNA (35). These findings
may point to the occurrence of an ND5 translation factor(s)
with tissue-specific regulation. In Saccharomyces cerevisiae,
several nucleus-encoded mitochondrial mRNA-specific trans-
lational activators have been identified that may play a rate-
limiting role in modulating mitochondrial gene expression in
response to environmental conditions (18).
The ND5 synthesis rate is rate limiting for complex I-de-
pendent respiration. The most striking observation of the
present analysis has been that the rate of ND5 protein synthe-
sis in r° LL/2-m21 transformants and ethidium bromide-de-
rived cell lines is rate limiting, or nearly so, for the assembly of
a functional complex I. A difference was observed between
malate-glutamate-dependent respiration and rotenone-sensi-
tive respiration, as concerns the rate of ND5 protein synthesis
required to support full respiration, which was found to cor-
respond to 100 and ;80%, respectively, of the mitochondrial
synthetic capacity for this protein. This difference is presum-
ably accounted for by the fact that the malate-glutamate-de-
pendent respiration rate in permeabilized cells measures the
maximum capacity of complex I-dependent respiration under
conditions where NADH and ubiquinone are not limiting. By
contrast, the rotenone-sensitive respiration rate in intact cells
gives an estimate of the contribution of complex I to the en-
dogenous respiration in various experimental situations. It is
reasonable to expect that, in different in vivo situations, the
ND5 protein synthesis rate required to support full endoge-
nous respiration may vary and may reach, under certain con-
ditions, the maximum synthetic capacity for this protein. Con-
sidering that the malate-glutamate-dependent respiration is
usually the rate-limiting step in respiration (27, 45), the sur-
prising conclusion of these experiments is that the synthesis of
ND5 is nearly rate limiting for respiration. Whether this con-
clusion also applies to the synthesis of other mtDNA-encoded
subunits of NADH dehydrogenase remains to be determined.
Implications for general mitochondrial function control and
for mitochondrial diseases. The picture of the regulation of
ND5 gene expression and its effect on respiration which has
emerged from the present work is one involving very low re-
serve capacities at the level of transcription, translation, and
respiration. This conclusion is in striking contrast to the large
excess of genetic potential of the eukaryotic mitochondrial
genome (3). Whether this tightness of control is unique for the
ND5 gene and possibly related to its translational regulation
needs to be established. However, it is pertinent to mention
here that the conclusions of these studies are consistent with
and extend previous findings from this laboratory. These ob-
servations had indicated that, in a considerable variety of hu-
man cell types, the COX capacity, measured in intact uncou-
pled cells or in digitonin-permeabilized cells in state 3, is in low
excess or nearly limiting, respectively, relative to the capacity
needed to support the endogenous or the glutamate-malate-
dependent respiration (45, 46). In a general sense, it is reason-
able to assume that an effective and fine modulation of activity
of a given biochemical pathway, such as to match the different
cellular needs in various physiological or developmental situ-
ations, would require a limiting level of at least one of the
components of the pathway. Therefore, the tightness of control
observed for ND5 gene expression in the present work may be
a paradigm of what occurs in many physiological and develop-
mental pathways.
In another context, the present observations have relevance
for understanding the pathogenetic role of disease-causing
mtDNA mutations that produce only a moderate decrease in
the activity of a given component of the respiratory chain (26,
28, 31, 36). Furthermore, they may help elucidate the basis for
the striking tissue specificity of the mutation-associated defects
and for the late onset of some of these disorders. Thus, it is
perfectly plausible that tissue-specific or age-related variations
in the rate of mitochondrial protein synthesis, which is under
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the control of nuclear genes, could, by affecting the expression
of a critical gene like ND5 and consequently the rate of res-
piration, be one of the critical factors underlying the tissue
specificity and the time of appearance of the disease pheno-
type.
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